130 related articles for article (PubMed ID: 12933627)
21. Estimating lifetime or episode-of-illness costs under censoring.
Basu A; Manning WG
Health Econ; 2010 Sep; 19(9):1010-28. PubMed ID: 20665908
[TBL] [Abstract][Full Text] [Related]
22. Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study).
Yoshida M; Matsuyama Y; Ohashi Y;
Clin Trials; 2007; 4(4):318-28. PubMed ID: 17848493
[TBL] [Abstract][Full Text] [Related]
23. Regression analysis of mean quality-adjusted lifetime with censored data.
Wang H; Zhao H
Biostatistics; 2007 Apr; 8(2):368-82. PubMed ID: 16877496
[TBL] [Abstract][Full Text] [Related]
24. Estimating net survival: the importance of allowing for informative censoring.
Danieli C; Remontet L; Bossard N; Roche L; Belot A
Stat Med; 2012 Apr; 31(8):775-86. PubMed ID: 22281942
[TBL] [Abstract][Full Text] [Related]
25. Regression modeling of competing crude failure probabilities.
Fine JP
Biostatistics; 2001 Mar; 2(1):85-97. PubMed ID: 12933558
[TBL] [Abstract][Full Text] [Related]
26. Modeling survival data with informative cluster size.
Williamson JM; Kim HY; Manatunga A; Addiss DG
Stat Med; 2008 Feb; 27(4):543-55. PubMed ID: 17640035
[TBL] [Abstract][Full Text] [Related]
27. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
[TBL] [Abstract][Full Text] [Related]
28. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data.
Moodie PF; Nelson NA; Koch GG
Stat Med; 2004 Apr; 23(7):1075-93. PubMed ID: 15057879
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity analysis for informative censoring in parametric survival models.
Siannis F; Copas J; Lu G
Biostatistics; 2005 Jan; 6(1):77-91. PubMed ID: 15618529
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal analysis of censored medical cost data.
Başer O; Gardiner JC; Bradley CJ; Yüce H; Given C
Health Econ; 2006 May; 15(5):513-25. PubMed ID: 16389670
[TBL] [Abstract][Full Text] [Related]
31. Partial least squares dimension reduction for microarray gene expression data with a censored response.
Nguyen DV
Math Biosci; 2005 Jan; 193(1):119-37. PubMed ID: 15681279
[TBL] [Abstract][Full Text] [Related]
32. Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology.
Nelson CL; Sun JL; Tsiatis AA; Mark DB
Stat Med; 2008 Nov; 27(26):5525-55. PubMed ID: 18613251
[TBL] [Abstract][Full Text] [Related]
33. Smooth quantile ratio estimation with regression: estimating medical expenditures for smoking-attributable diseases.
Dominici F; Zeger SL
Biostatistics; 2005 Oct; 6(4):505-19. PubMed ID: 15872022
[TBL] [Abstract][Full Text] [Related]
34. Regression methods for cost-effectiveness analysis with censored data.
Willan AR; Lin DY; Manca A
Stat Med; 2005 Jan; 24(1):131-45. PubMed ID: 15515137
[TBL] [Abstract][Full Text] [Related]
35. Non-parametric paired two-sample tests for censored survival data incorporating longitudinal covariate information.
Messinger S; Murray S
Stat Med; 2005 Jan; 24(2):301-18. PubMed ID: 15558696
[TBL] [Abstract][Full Text] [Related]
36. Induced smoothing for rank regression with censored survival times.
Brown BM; Wang YG
Stat Med; 2007 Feb; 26(4):828-36. PubMed ID: 16646005
[TBL] [Abstract][Full Text] [Related]
37. Bayesian proportional hazards model with time-varying regression coefficients: a penalized Poisson regression approach.
Lambert P; Eilers PH
Stat Med; 2005 Dec; 24(24):3977-89. PubMed ID: 16320263
[TBL] [Abstract][Full Text] [Related]
38. Estimating marginal and incremental effects on health outcomes using flexible link and variance function models.
Basu A; Rathouz PJ
Biostatistics; 2005 Jan; 6(1):93-109. PubMed ID: 15618530
[TBL] [Abstract][Full Text] [Related]
39. Residual analysis in linear regression models with an interval-censored covariate.
Topp R; Gómez G
Stat Med; 2004 Nov; 23(21):3377-91. PubMed ID: 15490424
[TBL] [Abstract][Full Text] [Related]
40. Estimation of the marginal survival time in the presence of dependent competing risks using inverse probability of censoring weighted (IPCW) methods.
Matsuyama Y; Yamaguchi T
Pharm Stat; 2008; 7(3):202-14. PubMed ID: 17554753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
